Eyeing China, Senate intel panel leaders urge export controls on biotech

The Commerce Department should implement an export-control regime in the biotechnology sector akin to its approach to the semiconductor industry, the leaders of the Senate Intelligence Committee argued this week, citing China’s push to use biotech to “advance its military capabilities and ambitions, undermine U.S. security, and continue its egregious violations of human rights.” In a Feb. 28 letter to Commerce Secretary Gina Raimondo, intel panel Chair Mark Warner (D-VA) and Vice Chair Marco Rubio (R-FL) say the department has...